Morgan Stanley’s Compass Therapeutics CMPX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$1.91M Sell
360,372
-4,873
-1% -$28.1K ﹤0.01% 4801
2025
Q4
$1.96M Buy
365,245
+178,293
+95% +$823K ﹤0.01% 4825
2025
Q3
$654K Sell
186,952
-61,797
-25% -$195K ﹤0.01% 5393
2025
Q2
$647K Sell
248,749
-590,427
-70% -$1.22M ﹤0.01% 5336
2025
Q1
$1.59M Buy
839,176
+460,624
+122% +$1.22M ﹤0.01% 4749
2024
Q4
$549K Buy
378,552
+665
+0.2% +$1.1K ﹤0.01% 5381
2024
Q3
$695K Buy
377,887
+209,971
+125% +$262K ﹤0.01% 5242
2024
Q2
$168K Buy
167,916
+3,685
+2% +$5.38K ﹤0.01% 5750
2024
Q1
$325K Sell
164,231
-291,749
-64% -$504K ﹤0.01% 5520
2023
Q4
$711K Buy
455,980
+392,691
+620% +$679K ﹤0.01% 5461
2023
Q3
$125K Sell
63,289
-55,607
-47% -$137K ﹤0.01% 5779
2023
Q2
$378K Sell
118,896
-41,168
-26% -$129K ﹤0.01% 5356
2023
Q1
$523K Buy
160,064
+95,566
+148% +$375K ﹤0.01% 5229
2022
Q4
$324K Buy
64,498
+55,626
+627% +$222K ﹤0.01% 5452
2022
Q3
$20K Buy
8,872
+8,259
+1,347% +$22.9K ﹤0.01% 6790
2022
Q2
$2K Sell
613
-26,364
-98% -$57.2K ﹤0.01% 7573
2022
Q1
$37K Buy
26,977
+9,504
+54% +$19.6K ﹤0.01% 6843
2021
Q4
$56K Buy
+17,473
New +$57.9K ﹤0.01% 6756

Other funds holding CMPX